Results 1 to 10 of about 2,443,481 (150)

A seroepidemiological survey of adenovirus type 7 circulation among healthy adults in China and in Sierra Leone, West Africa

open access: yesFrontiers in Public Health, 2023
Adenovirus type 7 (HAdV7) is one of the most pathogenic human adenoviruses (HAdVs) and can cause severe illness and even death, particularly in people with weakened immune systems.
Busen Wang   +12 more
doaj   +1 more source

Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology

open access: yesVeterinary Research, 2021
Brucella spp. are Gram-negative, facultative intracellular bacteria that cause brucellosis in humans and various animals. The threat of brucellosis has increased, yet currently available live attenuated vaccines still have drawbacks.
Xiaodong Zai   +8 more
doaj   +1 more source

Dual-target Bridging ELISA for Bispecific Antibodies

open access: yesBio-Protocol, 2022
Bispecific antibodies (BsAbs) are typically monoclonal antibody (mAb)–derived molecular entities engineered to bind to two distinct targets, including two antigens or two epitopes on the same antigen.
Min Pei   +5 more
doaj   +1 more source

Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity

open access: yesScientific Reports, 2021
High tumor regulatory T (Treg) cell infiltration is associated with poor prognosis of many cancers. CD25 is highly expressed on tumor Treg cells and is a potential target for Treg deletion.
Deyong Song   +14 more
doaj   +1 more source

A novel Galleria mellonella experimental model for zoonotic pathogen Brucella

open access: yesVirulence, 2023
Brucellosis is a major threat to public health and animal husbandry. Several in vivo vertebrate models, such as mice, guinea pigs, and nonhuman primates, have been used to study Brucella pathogenesis, bacteria-host interactions, and vaccine efficacy ...
Shuyi Wang   +11 more
doaj   +1 more source

A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques

open access: yesnpj Vaccines, 2023
Rift Valley fever virus (RVFV) is listed as a priority pathogen by the World Health Organization (WHO) because it causes serious and fatal disease in humans, and there are currently no effective countermeasures.
Ting Bian   +13 more
doaj   +1 more source

A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants

open access: yesVaccines, 2022
With the emergence and rapid spread of new pandemic variants, especially variants of concern (VOCs), the development of next-generation vaccines with broad-spectrum neutralizing activities is of great importance.
Rui Wang   +19 more
doaj   +1 more source

In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance

open access: yesCommunications Biology, 2021
Lu Shan et al. present a structure-guided approach to engineer a monovalent form of the fragment crystallizable (Fc) region of an IgG4 antibody to adapt multiple versions of half-life extension modifications and bispecific targeting.
Lu Shan   +12 more
doaj   +1 more source

Authorship Weightage Algorithm for Academic Publications: A New Calculation and ACES Webserver for Determining Expertise

open access: yesMethods and Protocols, 2021
Despite the public availability, finding experts in any field when relying on academic publications can be challenging, especially with the use of jargons.
Wei-Ling Wu   +5 more
doaj   +1 more source

IgG Fc engineering to modulate antibody effector functions

open access: yesProtein & Cell, 2017
Therapeutic monoclonal antibodies are among the most effective biotherapeutics to date. An important aspect of antibodies is their ability to bind antigen while at the same time recruit immune effector functions.
Xinhua Wang   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy